Some of these disrupted inflammatory mediators, like CXCL11, CXCL20, IL-6, IL-1β, are involved in the pathogenesis of autoimmune disorders and play a potential role in tumor progression and metastasis [33,34,35,36,37]. This evidence concerns the gene CXCL11 and autoimmune disease.